Greater Trochanteric Pain Syndrome: Efficacy of Ultrasound Guided Platelet-rich Plasma vs Needle Tenotomy.
Status:
Recruiting
Trial end date:
2021-12-15
Target enrollment:
Participant gender:
Summary
Great trochanteric pain syndrome (GTPS) is a difficult problem to manage and result in
significant patient morbidity. This study is a single-center, randomised double-blind
controlled trial. Eighty patients will be allocated to have ultrasound (US)-guided injection
of pure platelet-rich plasma (PRP) or needle tenotomy. Outcome data will be collected before
the intervention, and at 3, 6 and 12 months after intervention. Main outome measure: percent
of patients that experience a reduction of 25% in hip outcome score (HOS) (responders) at 6
months after intervention. Secondary outcome measures include percent of responders at three
and twelve months, pain reduction (VAS) at 3, 6 and 12 months. Adverse reactions or events
will be recorded.